Literatur
Zimmerli W, Widmer AF, Blatter M et al (1998) Role of rifampin for treatment of orthopedic implantrelated staphylococcal infections: a randomized controlledtrial. Foreign-Body Infection (FBI) Study Group. JAMA 279:1537–1541
El Helou OC, Berbari EF, Lahr BD et al (2010) Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis 29:961–967
Widmer AF, Wiestner A, Frei R et al (1991) Killing of nongrowing and adherent Escherichia Coli determines drug efficacy indevice related infections. Antimicrob Agents Chemother 35:741–746
Grassi L et al (2017) Generation of persister cells of pseudomonas aeruginosa and Staphylococcus Aureus by chemical treatment and evaluation of their susceptibility to membrane-targeting agents. Front Microbiol 8:1917. https://doi.org/10.3389/fmicb.2017.01917
Renz N, Trampuz A (2015) Periprothetische Infektionen: aktueller Stand der Diagnostik und Therapie. Orthopädie Rheuma 18(6):20–28
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Feihl, N. Renz und A. Trampuz geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Feihl, S., Renz, N. & Trampuz, A. Neue Konzepte zur Eradikation von Biofilmen auf Implantaten. Unfallchirurg 120, 1092–1093 (2017). https://doi.org/10.1007/s00113-017-0437-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00113-017-0437-8